Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

• Status: Completed
• Trial end date: 2013-06-01

Summary

To compare tenofovir DF plus lamivudine plus efavirenz vs. stavudine plus lamivudine plus efavirenz in the treatment of HIV-1-infected patients who have never taken antiretroviral drugs and have a viral load of less than 400 copies/mL at week 48.

• Phase: Phase 3

Details

• Lead Sponsor: Gilead Sciences
• Treatments: Efavirenz; Lamivudine; Stavudine; Tenofovir